Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0276 EUR | -8.00% | +4.55% | +81.58% |
06-11 | Acarix Announces Enrollment of First Patient in Us-Based Clinical Workflow Evaluation Study | CI |
05-27 | Acarix AB Appoints Jeff Thomas as the New Head of US Sales, Effective June 1, 2024 | CI |
- Stock Market
- Equities
- ACARIX Stock
- 7AC Stock
- News Acarix AB
- Trading Ideas